Skip to main content
OpenTrials

Clinical trial condition

Intestinal Diseases

Explore clinical trials studying Intestinal Diseases. Study availability and eligibility vary by location and protocol.

11,848 public trials 2,285 recruiting studies
Refine in advanced search Browse all conditions

Intestinal Diseases trial results

Completed

A Study to Investigate Efficacy and Safety of Cobimetinib Plus Atezolizumab and Atezolizumab Monotherapy Versus Regorafenib in Participants With Metastatic Colorectal Adenocarcinoma (COTEZO IMblaze370)

NCT02788279

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Yale Cancer Center; Medical Oncology New Haven, Connecticut, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • Florida Cancer Specialists; SCRI Fort Myers, Florida, United States
View all 73 locations
View Trial Details
Completed

(CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis

NCT00679432

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Santarus Clinical Investigational Site 5051 Huntsville, Alabama, United States
  • Santarus Clinical Investigational Site 5102 Mobile, Alabama, United States
  • Santarus Clinical Investigational Site 5014 Sylacauga, Alabama, United States
  • Santarus Clinical Investigational Site 5088 Tucson, Arizona, United States
View all 105 locations
View Trial Details
Completed

(CB-01-02/02) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis

NCT00679380

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • Centre for Digestive Diseases Sydney, New South Wales, Australia
  • Royal Adelaide Hospital Adelaide, Australia
  • Box Hill Hospital, Department of Gastroenterology Clive Ward Centre, Box Hill, Australia
  • The Alfred Hospital Melbourne, Australia
View all 71 locations
View Trial Details
Completed

A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors

NCT02335918

Conditions
Adenocarcinoma, Astrocytoma, Carcinoma, +37 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • The Stanford Center for Clinical and Translational Education and Research Palo Alto, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • University of Colorado Medical Center Aurora, Colorado, United States
View all 19 locations
View Trial Details

Related conditions